Filing Details

Accession Number:
0001415889-21-004514
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-09-21 19:17:55
Reporting Period:
2021-09-17
Accepted Time:
2021-09-21 19:17:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1786240 E Rowan Chapman C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-09-17 5,500 $32.15 10,356 No 4 M Direct
Common Stock Disposition 2021-09-17 1,000 $120.08 9,356 No 4 S Direct
Common Stock Disposition 2021-09-17 4,500 $120.93 4,856 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-09-17 5,500 $0.00 5,500 $32.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
11,000 2029-09-26 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2021. The Reporting Person is subject to a Lock-up Letter Agreement that expired on September 19, 2021. The sale of shares is a permissible exemption under the terms of the Lock-Up Letter Agreement.
  2. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.46 to $120.38 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.48 to $121.30 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. These reported shares are subject to restrictions in the Lock-Up Letter Agreement.
  5. The option shares vest over three years. A third of the option shares vested and became exercisable on August 15, 2020 and the remaining shares vest in 2 equal annual installments thereafter.